Ledger.Open graph →
SEC Form D · filed July 8, 2015

GENSIGHT BIOLOGICS S.A

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Paris, I0
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Nitza Thomasson · Paris, I0ExecMichael S. Wyzga · Paris, I0DirectorNitza Thomasson · Paris, I0ExecJean-Philippe Combal · Paris, I0ExecPeter Goodfellow · Leiden, P7DirectorThomas Gidoin · Paris, I0ExecGenghis Lloyd-Harris · Paris, I0DirectorJean-Philippe Combal · Paris, I0ExecBernard Gilly · Waltham, MAExec · DirectorFlorent Gros · Paris, I0DirectorPeter Goodfellow · Leiden, P7DirectorDidier Pruneau · Paris, I0ExecGuido Magni · Turku, H9DirectorGenghis Lloyd-Harris · Paris, I0DirectorFlorent Gros · Paris, I0DirectorBernard Gilly · Paris, I0Exec · DirectorGuido Magni · TURKU, H9DirectorThomas Gidoin · Paris, I0ExecMichael S. Wyzga · Paris, I0DirectorDidier Pruneau · Paris, I0Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗